JP2008035714A - 健康食品 - Google Patents
健康食品 Download PDFInfo
- Publication number
- JP2008035714A JP2008035714A JP2006210207A JP2006210207A JP2008035714A JP 2008035714 A JP2008035714 A JP 2008035714A JP 2006210207 A JP2006210207 A JP 2006210207A JP 2006210207 A JP2006210207 A JP 2006210207A JP 2008035714 A JP2008035714 A JP 2008035714A
- Authority
- JP
- Japan
- Prior art keywords
- astaxanthin
- anthocyanin
- effect
- health food
- muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 23
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 48
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 46
- 239000001168 astaxanthin Substances 0.000 claims abstract description 46
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 46
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 46
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 38
- 239000004410 anthocyanin Substances 0.000 claims abstract description 38
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 38
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 38
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 40
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 20
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 20
- 108010085443 Anserine Proteins 0.000 claims description 17
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 claims description 17
- 241000210053 Potentilla elegans Species 0.000 claims description 17
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 claims description 17
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 15
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 15
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 15
- 241000168525 Haematococcus Species 0.000 claims description 3
- 229940102480 bilberry extract Drugs 0.000 claims description 2
- 235000019209 bilberry extract Nutrition 0.000 claims description 2
- 235000001497 healthy food Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 61
- 210000003205 muscle Anatomy 0.000 abstract description 20
- 230000017531 blood circulation Effects 0.000 abstract description 19
- 230000006870 function Effects 0.000 abstract description 13
- 206010049565 Muscle fatigue Diseases 0.000 abstract description 8
- 230000004438 eyesight Effects 0.000 abstract description 6
- 208000029549 Muscle injury Diseases 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 4
- 230000002045 lasting effect Effects 0.000 abstract 1
- 230000000007 visual effect Effects 0.000 description 17
- 230000004304 visual acuity Effects 0.000 description 15
- 210000004556 brain Anatomy 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 12
- 102000004330 Rhodopsin Human genes 0.000 description 12
- 108090000820 Rhodopsin Proteins 0.000 description 12
- 230000009471 action Effects 0.000 description 12
- 208000003464 asthenopia Diseases 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000001525 retina Anatomy 0.000 description 10
- 230000006872 improvement Effects 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 210000001328 optic nerve Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000962514 Alosa chrysochloris Species 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000004382 visual function Effects 0.000 description 4
- 244000078534 Vaccinium myrtillus Species 0.000 description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001617 migratory effect Effects 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 150000001514 astaxanthins Chemical class 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 230000004297 night vision Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000208422 Rhododendron Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
【解決手段】アントシアニン及びアスタキサンチンを主成分としたことを特徴とする健康食品。
【選択図】図1
Description
・モニター対象者
社会人野球選手9名(他のサプリメントを摂取していない,病院にかかっていな
い(病気を患っていない)及び規則的な生活(食生活)を送っている9名。)に対し、
1日二粒を4週間連続で服用し、次の検査を行った。
まず、自覚症状として、眼精疲労と肉体疲労を自己評価(この評価はあくまでも
モニター自身の主観的な評価)してもらい、次に、客観的評価として静止視力の測
定と動体視力の測定(移動する標的が、停止している標的と一致した時にスイッチ
を押し、その距離の誤差の値を測定する。この測定には、ニデック社製の動体視力
計KV−100を使用)した結果を図2に示した。
現状維持のものを△、効果がなかったものを×とし、効果があったものの○だけを
1ポイントと換算し、合計ポイントで総合効果評価とし数値で表した。
毎日摂取した。
摂取後の自覚症状では、眼の疲労感,体の疲労感ともに9人中4人が改善効果を
示したことが確認された。静止視力の測定では、9人中6人が改善効果を示し、動
体視力の測定でも、9人中5人が改善効果を示したことが確認された。
確認され、9人全員が評価項目の1つ以上の改善効果を示したことが確認された。
Claims (5)
- アントシアニン及びアスタキサンチンを主成分としたことを特徴とする健康食品。
- 請求項1記載の健康食品において、アントシアニンはビルベリーエキス由来のものであり、アスタキサンチンはヘマトコッカス藻抽出物由来のものであることを特徴とする健康食品。
- 請求項1〜2いずれか1項に記載の健康食品において、前記アントシアニンが4〜10重量%、前記アスタキサンチンが0.5〜1.5重量%配合されていることを特徴とする健康食品。
- 請求項1〜3いずれか1項記載の健康食品において、ドコサヘキサエン酸、共役リノール酸及びアンセリンが配合されていることを特徴とする健康食品。
- 請求項4記載の健康食品において、前記ドコサヘキサエン酸が3〜8重量%、前記共役リノール酸が1〜3重量%及び前記アンセリンが0.1〜0.5重量%配合されていることを特徴とする健康食品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006210207A JP2008035714A (ja) | 2006-08-01 | 2006-08-01 | 健康食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006210207A JP2008035714A (ja) | 2006-08-01 | 2006-08-01 | 健康食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008035714A true JP2008035714A (ja) | 2008-02-21 |
Family
ID=39171481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006210207A Pending JP2008035714A (ja) | 2006-08-01 | 2006-08-01 | 健康食品 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008035714A (ja) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012246244A (ja) * | 2011-05-26 | 2012-12-13 | Fuji Chem Ind Co Ltd | 毛細血管退行抑制剤 |
| JP2013163669A (ja) * | 2012-01-12 | 2013-08-22 | Oriza Yuka Kk | 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤 |
| WO2013125135A1 (ja) * | 2012-02-24 | 2013-08-29 | 株式会社フードエビデンスリサーチ | アントシアニン吸収促進組成物 |
| JP2013216621A (ja) * | 2012-04-10 | 2013-10-24 | Partners Inc | 排尿障害改善剤 |
| JP2015086165A (ja) * | 2013-10-30 | 2015-05-07 | 株式会社東洋新薬 | 筋芽細胞増殖促進剤及びピント調整機能改善剤 |
| JP2016183121A (ja) * | 2015-03-26 | 2016-10-20 | 株式会社ファンケル | 肩こり及び/又は目の充血改善剤 |
| JP2017012075A (ja) * | 2015-06-30 | 2017-01-19 | 株式会社 伊藤園 | アスタキサンチンを含有する果汁含有飲料及びその製造方法 |
| JP2018095658A (ja) * | 2018-02-09 | 2018-06-21 | 株式会社東洋新薬 | 筋芽細胞増殖促進剤及びピント調整機能改善剤 |
| CN108606325A (zh) * | 2018-05-09 | 2018-10-02 | 哈尔滨工业大学 | 一种抗震救灾人员专用抗疲劳应激速溶冲剂的制备方法 |
| CN109481416A (zh) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | 一种虾青素软胶囊 |
| WO2021033599A1 (ja) * | 2019-08-16 | 2021-02-25 | 株式会社プラチナヘボン | 動体視力の改善剤並びに動体視力の改善方法 |
| JPWO2023058123A1 (ja) * | 2021-10-05 | 2023-04-13 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002338473A (ja) * | 2001-05-15 | 2002-11-27 | Yaizu Suisankagaku Industry Co Ltd | 抗疲労組成物 |
| WO2002094253A1 (en) * | 2001-05-24 | 2002-11-28 | Fuji Chemical Industry Co., Ltd. | Agents for relieving eye controlling function error |
| JP2003238442A (ja) * | 2002-02-19 | 2003-08-27 | Sunnyhealth Co Ltd | 眼健康指向性組成物 |
| JP2005041851A (ja) * | 2003-07-23 | 2005-02-17 | Makoto Yafuji | ビタミンを主材とするイオン化ミネラル結合型サプリメント |
| WO2005061684A1 (ja) * | 2003-12-22 | 2005-07-07 | Wakunaga Pharmaceutical Co., Ltd. | 油脂組成物 |
| WO2005074962A1 (ja) * | 2004-02-10 | 2005-08-18 | Asahi Breweries, Ltd. | 筋張力増強剤 |
| JP2006008532A (ja) * | 2004-06-22 | 2006-01-12 | Juntendo | 共役脂肪酸を有効成分とする運動能力改善剤 |
-
2006
- 2006-08-01 JP JP2006210207A patent/JP2008035714A/ja active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002338473A (ja) * | 2001-05-15 | 2002-11-27 | Yaizu Suisankagaku Industry Co Ltd | 抗疲労組成物 |
| WO2002094253A1 (en) * | 2001-05-24 | 2002-11-28 | Fuji Chemical Industry Co., Ltd. | Agents for relieving eye controlling function error |
| JP2003238442A (ja) * | 2002-02-19 | 2003-08-27 | Sunnyhealth Co Ltd | 眼健康指向性組成物 |
| JP2005041851A (ja) * | 2003-07-23 | 2005-02-17 | Makoto Yafuji | ビタミンを主材とするイオン化ミネラル結合型サプリメント |
| WO2005061684A1 (ja) * | 2003-12-22 | 2005-07-07 | Wakunaga Pharmaceutical Co., Ltd. | 油脂組成物 |
| WO2005074962A1 (ja) * | 2004-02-10 | 2005-08-18 | Asahi Breweries, Ltd. | 筋張力増強剤 |
| JP2006008532A (ja) * | 2004-06-22 | 2006-01-12 | Juntendo | 共役脂肪酸を有効成分とする運動能力改善剤 |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012246244A (ja) * | 2011-05-26 | 2012-12-13 | Fuji Chem Ind Co Ltd | 毛細血管退行抑制剤 |
| JP2013163669A (ja) * | 2012-01-12 | 2013-08-22 | Oriza Yuka Kk | 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤 |
| WO2013125135A1 (ja) * | 2012-02-24 | 2013-08-29 | 株式会社フードエビデンスリサーチ | アントシアニン吸収促進組成物 |
| JP2013216621A (ja) * | 2012-04-10 | 2013-10-24 | Partners Inc | 排尿障害改善剤 |
| JP2015086165A (ja) * | 2013-10-30 | 2015-05-07 | 株式会社東洋新薬 | 筋芽細胞増殖促進剤及びピント調整機能改善剤 |
| JP2016183121A (ja) * | 2015-03-26 | 2016-10-20 | 株式会社ファンケル | 肩こり及び/又は目の充血改善剤 |
| JP2017012075A (ja) * | 2015-06-30 | 2017-01-19 | 株式会社 伊藤園 | アスタキサンチンを含有する果汁含有飲料及びその製造方法 |
| JP2018095658A (ja) * | 2018-02-09 | 2018-06-21 | 株式会社東洋新薬 | 筋芽細胞増殖促進剤及びピント調整機能改善剤 |
| CN108606325A (zh) * | 2018-05-09 | 2018-10-02 | 哈尔滨工业大学 | 一种抗震救灾人员专用抗疲劳应激速溶冲剂的制备方法 |
| CN109481416A (zh) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | 一种虾青素软胶囊 |
| WO2021033599A1 (ja) * | 2019-08-16 | 2021-02-25 | 株式会社プラチナヘボン | 動体視力の改善剤並びに動体視力の改善方法 |
| JPWO2023058123A1 (ja) * | 2021-10-05 | 2023-04-13 | ||
| WO2023058123A1 (ja) * | 2021-10-05 | 2023-04-13 | BGG Japan株式会社 | 視力向上用の組成物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Škėmienė et al. | Peculiarities of medical students’ nutrition | |
| JP2010270095A (ja) | 認知行動能力向上剤 | |
| Mueller et al. | The athlete's guide to sports supplements | |
| JP2008035714A (ja) | 健康食品 | |
| Spector | The diet myth: The real science behind what we eat | |
| CA3052324C (en) | Multi-nutrient composition | |
| Murray | The Complete Book of Juicing, Revised and Updated: Your Delicious Guide to Youthful Vitality | |
| Blum | Cavewomen Don't Get Fat: The Paleo Chic Diet for Rapid Results | |
| Chatterjee | Endurance Sports and | |
| Applegate | Encyclopedia of sports & fitness nutrition | |
| Miller | Raising Disease Free Kids: Inculcate Healthy Eating Habits & Lifestyle To Fight Diet Related Diseases | |
| Hendricks | POTS, MCAS, and Hypermobility: The Triple Threat Handbook–An Integrated Guide to Diet, Exercise, and Daily Living | |
| Clayton et al. | 8 The Role of Nutrition in Musculoskeletal Injury and | |
| do Carmo et al. | Micronutrients and Polyphenols: Catalysts and Protectors | |
| Ghosh et al. | Endurance Sports and Its Related Nutritional Requirements | |
| Cole et al. | Nourishing Sports and Recovery Drinks | |
| Lydon | Ten Years Thinner: 6 Weeks to a Leaner, Younger-Looking You | |
| Hannon et al. | 17 Nutritional Strategies for Young Athletes | |
| Mike | Contact and Combat Sports: Sports Nutrition Benefits | |
| Zinczenko | Zero Belly Diet: Lose Up to 16 Lbs. in 14 Days! | |
| Webb | Older, Faster, Stronger: What Women Runners Can Teach Us All about Living Younger, Longer | |
| GUȚĂ et al. | Dietary supplements and exercise capacity in professional rugby players. | |
| Anderson | Analyzing Sports Drinks | |
| Johnson | New Prescription for Childhood Obesity: Fight Childhood Obesity with Antioxidants & Phytonutrients | |
| Cdn et al. | The Misled Athlete: Effective Nutritional and Training Strategies Without the Need for Steroids, Stimulants and Banned Substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090803 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20091221 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20100325 |
|
| A072 | Dismissal of procedure |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20100713 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20101214 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101227 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110225 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110428 |